000 01160nas a22002895i 4500
003 EG-CaNGU
005 20240220121332.0
008 220809t2019 enka fr 001 0 eng d
020 _a9780857113658
040 _aEG-CaNGU
_beng
_cEG-CaNGU
_dEG-CaNGU
_erda
082 0 4 _a615.1341
_bBNF
_223
130 0 _91081
_aBritish National Formulary.
_n79,
_fMarch - September 2020.
245 1 0 _aBNF.
_n79 :
_bMarch - September 2020 /
246 3 3 _aBritish National Formulary.
_n79 :
_bMarch - September 2020
264 1 _aLondon, England :
_bBMJ Group,
_bPharmaceutical Press,
_c[2019]
264 4 _c©2019
300 _axvii, 1716 pages :
_billustrations ;
_c21 cm
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
500 _aIncludes index.
650 7 _aPharmacopoeias.
_2NGU-sh
_94239
650 7 _aPharmacopoeias
_zGreat Britain.
_2NGU-sh
_92575
650 7 _aMedicine.
_2NGU-sh
_91456
710 2 _aBritish Medical Association,
_eauthor.
_91086
710 2 _aRoyal Pharmaceutical Society of Great Britain,
_eauthor.
_91088
999 _c932
_d932